Massivemarkets

MYO

Myomo Inc.

NYSE American · usd

$1.22+0.01 (+0.83%)
As of 2:24:22 PM EDT on Oct 26, 2026 · 15-minute delayed

Myomo Inc. (MYO) trades at $1.22 (+0.83%) as of 2:24:22 PM EDT on Oct 26, 2026, -24.22% over the past month. Market cap is $47.93M, with 2.6 days to cover in short interest.

Stock performance

How Myomo Inc. (MYO) stock has performed from one day to one year, with its 52-week range.

+0.85%
+$0.01 over 1D
$1.17$1.19$1.20$1.228:05 AM10:25 AM11:40 AM1:05 PM2:20 PM$1.21
1D
+0.83%
1W
-2.40%
1M
-24.22%
YTD
+34.07%
1Y
+14.02%
52-wk range
$0.61 – $1.89

Key statistics

Today's trading snapshot for MYO: day range, open, previous close, volume and market cap.

Day range
$1.17 – $1.22
Open
$1.22
Prev close
$1.21
Volume
99.32K
Market cap
$47.93M
Shares out
39.61M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Myomo Inc.: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
1.11
P/B
8.22
P/FCF
—
ROE
-248.9%
ROA
-41.0%
Debt/Equity
2.05
Div yield
0.00%

As of Oct 23, 2026

8-K filings

Material corporate events Myomo Inc. has disclosed to the SEC on Form 8-K.

  • Charter amendmentJun 26, 2026

    The Company's stockholders approved an amendment to the Company's Eighth Amended and Restated Certificate of Incorporation, as amended (the 'Charter Amendment'), to increase the Company's authorized number of shares of common stock to 100,000,000 shares. On June 25, 2026, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware and the Charter Amendment became effective upon filing.

  • Executive compensation changeApr 16, 2026

    In connection with his appointment to the Board, Mr. Febbo was granted 45,000 restricted stock units ("RSUs"), which will vest in their entirety on the first anniversary of the effective date of his appointment to the Board. As a non-employee director, Mr. Febbo will also receive an annual cash retainer of $60,000. In addition, Mr. Febbo will be entitled to receive $85,000 annually, paid in the form of RSUs, which vest over four quarters.

  • Executive compensation changeDec 16, 2025

    Paul Gudonis, the Company's Chief Executive Officer, voluntarily elected to reduce his base salary for 2026 by 10% in exchange for RSUs with an aggregate grant date fair value equal to 115% of the amount of salary foregone ($40,000), and David Henry, the Chief Financial Officer of the Company, voluntarily elected to reduce his base salary for 2026 by 10% in exchange for RSUs with an aggregate grant date fair value equal to 115% of the amount of salary foregone ($30,000).

  • Warrant or conversionNov 10, 2025

    On the Closing Date and pursuant to the funding of Tranche 1 under the Loan Agreement, the Company issued to the Lender a warrant to purchase up to $1,312,500 worth of shares of the Company's common stock. The Warrant expires on November 4, 2030 and has an exercise price per share equal to the lesser of (i) $0.96 and (ii) the price per share of the Company's next bona fide round of equity financing before June 30, 2026.

  • Capital allocation updateJun 18, 2025

    In connection with its Investor & Analyst Day, on June 18, 2025, the Company issued a press release providing highlights for the event, including elements of the Company's long term financial model.

Dividend history and stock splits

Myomo Inc.'s recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-30Jan 31, 2020

MYO short interest

How heavily MYO is shorted: shares short, days to cover and average daily volume.

Days to cover
2.6
Short interest
1.07M
Avg volume
406.83K

As of · reported to FINRA twice monthly.

MYO news

The latest news and headlines about Myomo Inc. (MYO).

Frequently asked questions

What is the Myomo Inc. (MYO) stock price today?

Myomo Inc. (MYO) is trading at $1.22 (+0.83% on the day) as of 2:24:22 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Myomo Inc.?

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical…

What is the short interest in MYO?

As of Sep 30, 2026, MYO has 1.07M shares short and 2.6 days to cover.

What exchange is MYO listed on?

Myomo Inc. (MYO) trades on NYSE American in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.

Build with AI

Build an analysis of MYO with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a MYO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.